BRPI0408293A - utilização de um composto - Google Patents

utilização de um composto

Info

Publication number
BRPI0408293A
BRPI0408293A BRPI0408293-1A BRPI0408293A BRPI0408293A BR PI0408293 A BRPI0408293 A BR PI0408293A BR PI0408293 A BRPI0408293 A BR PI0408293A BR PI0408293 A BRPI0408293 A BR PI0408293A
Authority
BR
Brazil
Prior art keywords
analgesic
alkyl
methyl
neuropathic
day
Prior art date
Application number
BRPI0408293-1A
Other languages
English (en)
Inventor
Francis Colpaert
Bernard Vacher
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of BRPI0408293A publication Critical patent/BRPI0408293A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

"UTILIZAçãO DE UM COMPOSTO". A presente invenção refere-se à utilização de um composto de fórmula (I) e de seus sais terapeuticamente aceitáveis nos quais notadamente u representa um radical metila, v e w representam um átomo de hidrogênio, x representa um átomo de flúor, y representa um átomo de cloro e z representa um átomo de flúor, A representa um átomo de hidrogênio ou um grupo aminometila, bem como seus sais de adição com ácidos minerais ou orgânicos farmaceuticamente aceitáveis, para a preparação de um medicamento destinado ao tratamento curativo dos sintomas da dor crónica de origem neuropática ou psicogênica.
BRPI0408293-1A 2003-03-13 2004-03-15 utilização de um composto BRPI0408293A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0303099A FR2852244B1 (fr) 2003-03-13 2003-03-13 Utilisation de derives de pyridin-2-yl-methylamine pour la preparation d'un medicament destine au traitement des symptomes de la douleur chronique d'origine neuropathique ou psychogene
PCT/FR2004/000630 WO2004083171A2 (fr) 2003-03-13 2004-03-15 Utilisation de derives de pyridin-2-yl-methylamine pour le traitement des symptomes de la douleur chronique neuropathique ou psychogene

Publications (1)

Publication Number Publication Date
BRPI0408293A true BRPI0408293A (pt) 2006-03-07

Family

ID=32893267

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408293-1A BRPI0408293A (pt) 2003-03-13 2004-03-15 utilização de um composto

Country Status (25)

Country Link
US (1) US8609694B2 (pt)
EP (1) EP1603564B1 (pt)
JP (1) JP4684994B2 (pt)
KR (1) KR101100002B1 (pt)
CN (1) CN1761467B (pt)
AT (1) ATE366111T1 (pt)
AU (1) AU2004222051B2 (pt)
BR (1) BRPI0408293A (pt)
CA (1) CA2518591C (pt)
CY (1) CY1106900T1 (pt)
DE (1) DE602004007364T2 (pt)
DK (1) DK1603564T3 (pt)
ES (1) ES2289494T3 (pt)
FR (1) FR2852244B1 (pt)
HK (1) HK1079120A1 (pt)
IL (1) IL170743A (pt)
MX (1) MXPA05009782A (pt)
NO (1) NO334997B1 (pt)
NZ (1) NZ542461A (pt)
PL (1) PL1603564T3 (pt)
PT (1) PT1603564E (pt)
RU (1) RU2359674C2 (pt)
UA (1) UA81023C2 (pt)
WO (1) WO2004083171A2 (pt)
ZA (1) ZA200507634B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071778B2 (en) 2006-07-27 2011-12-06 Bristol-Myers Squibb Company Substituted heterocyclic ethers and their use in CNS disorders
WO2009096941A1 (en) * 2008-01-28 2009-08-06 Bristol-Myers Squibb Company Substituted heterocyclic ethers and their use in cns disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3925662B2 (ja) 1995-01-12 2007-06-06 グラクソ，グループ，リミテッド タキキニンアンタゴニスト活性を有するピペリジン誘導体
FR2755967B1 (fr) * 1996-11-21 1999-01-29 Pf Medicament Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments
FR2784378B1 (fr) * 1998-10-09 2000-12-29 Pf Medicament Nouveaux derives d'aryl-(4-fluoro-4-[(2-pyridin-2-yl- ethylamino)-methyl]-piperidin-1-yl)-methanone, leur procede de preparation et leur utilisation a titre de medicaments
FR2840900B1 (fr) * 2002-06-18 2005-02-25 Pf Medicament Nouveaux derives d'aryl[4-halogeno-4- [(heteroaryl-methylamino)-methyl]-piperidin-1-yl]-methanone, leur procede de preparation et leur utilisation a titre de medicaments

Also Published As

Publication number Publication date
EP1603564B1 (fr) 2007-07-04
RU2359674C2 (ru) 2009-06-27
AU2004222051B2 (en) 2009-01-15
JP4684994B2 (ja) 2011-05-18
DK1603564T3 (da) 2007-10-01
WO2004083171A3 (fr) 2004-12-23
CA2518591A1 (fr) 2004-09-30
DE602004007364D1 (de) 2007-08-16
AU2004222051A1 (en) 2004-09-30
US20060241141A1 (en) 2006-10-26
UA81023C2 (en) 2007-11-26
WO2004083171A2 (fr) 2004-09-30
ZA200507634B (en) 2006-06-28
MXPA05009782A (es) 2005-12-05
ES2289494T3 (es) 2008-02-01
KR101100002B1 (ko) 2011-12-28
PL1603564T3 (pl) 2007-12-31
RU2005131615A (ru) 2006-02-10
US8609694B2 (en) 2013-12-17
NZ542461A (en) 2008-10-31
IL170743A (en) 2011-11-30
DE602004007364T2 (de) 2008-03-06
CA2518591C (fr) 2012-05-15
CN1761467A (zh) 2006-04-19
CN1761467B (zh) 2011-09-21
HK1079120A1 (en) 2006-03-31
NO334997B1 (no) 2014-08-18
CY1106900T1 (el) 2012-09-26
IL170743A0 (en) 2009-02-11
KR20050106120A (ko) 2005-11-08
PT1603564E (pt) 2007-09-24
FR2852244A1 (fr) 2004-09-17
FR2852244B1 (fr) 2007-09-07
JP2006520370A (ja) 2006-09-07
ATE366111T1 (de) 2007-07-15
EP1603564A2 (fr) 2005-12-14
NO20054673L (no) 2005-10-11

Similar Documents

Publication Publication Date Title
KR101855357B1 (ko) 오피오이드 유도성 통각과민에서의 시그마 리간드의 용도
US9789117B2 (en) Use of sigma ligands in diabetes type-2 associated pain
ES2955490T3 (es) Métodos y composiciones para potenciar la acción de los analgésicos opioides mediante el uso de alcaloides de la iboga
SI1758853T1 (sl) Antagonisti glukagonskega receptorja priprava inuporaba v terapiji
WO2006049312A1 (ja) 神経因性疼痛治療剤
Mizobe et al. α2-Adrenoceptor agonists and anesthesia
ZA200510044B (en) Substituted 1,4-di-piperidin-4-yl-piperazine derivative combined with an opioid analgesic and their use for the treatment of pain and side-effects associated with opioid-based treatments
KR20110021823A (ko) 진통 내성 억제제
WO2002070524A3 (en) N-but-3-enyl norbuprenorphine and its use as analgesic
ATE403426T1 (de) Opioid-rezeptor-aktive 4-(3-hydroxyphenyl) oder 4-(3-alkoxyphenyl)-1,2,4-triazol-verbindungen
KR20060121178A (ko) 일과성 전신 열감, 충동 조절 장애 및 일반적인 의학상태로 인한 인격 변화 치료용 선택적 노르에피네프린재흡수 억제제
Horita et al. Effects of TRH on the central nervous system of the rabbit
CY1106900T1 (el) Χρηση παραγωγων πυριδιν-2-υλμεθυλαμινης για τη θεραπεια συμπτωματων χρονιου πονου νευροπαθους ή ψυχογενους προελευσης
JP3559572B2 (ja) 急性痛および慢性痛用鎮痛剤
US20070105940A1 (en) Method for treating pain
JPH05132430A (ja) 薬物従属症及び禁断症状の治療に関するグリシン／ｎｍｄａレセプターリガンドの用法
US20070259945A1 (en) Method for treating pain
DE60112725D1 (de) Phenoxyalkylaminderivate als agonisten des opioid-delta rezeptors
MX2022004610A (es) Uso de derivado de fenilquinolinona o derivado flavonoide para tratamiento del dolor neuropático.
ZA200702379B (en) Piperidine derivative or pharmaceutically acceptable salt thereof
Hass et al. Physiological effects of a novel bioactive agent
Ashton et al. Neuropharmacological profile of R 18 503-induced wet-shake behavior in the rat: Noradrenergic and opiate components
Xuelun et al. Analgesic effect of morphine added to bupivacaine in transversus abdominis plane block for total abdominal hysterectomy
MXPA02006374A (es) Combinacion de trimebutina con un opioide analgesico.
WO2018030382A1 (ja) モルヒナン誘導体

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 11 E 13 DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]